Patents by Inventor Eric R. Hugo

Eric R. Hugo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Small molecule prolactin receptor inhibitors, pharmaceutical compositions and treatment methods using such inhibitors
    Patent number: 11834423
    Abstract: Small molecule inhibitors (SMIs) of the Prolactin receptor, pharmaceutical compositions of the SMIs, and methods for treating patients suffering from disorders characterized increased expression or excitation of the Prolactin receptor, including breast cancer, prostate cancer and nociceptive pain disorders such as migraine headache, by administering pharmaceutical compositions of SMIs are provided.
    Type: Grant
    Filed: September 30, 2021
    Date of Patent: December 5, 2023
    Assignees: University of Cincinnati, University of Texas System, The Hebrew University of Jerusalem
    Inventors: Nira Ben-Jonathan, Eric R. Hugo, Edward J. Merino, Abraham J. Domb, Armen N. Akopian
  • Small Molecule Prolactin Receptor Inhibitors, Pharmaceutical Compositions and Treatment Methods Using Such Inhibitors
    Publication number: 20220024881
    Abstract: Small molecule inhibitors (SMIs) of the Prolactin receptor, pharmaceutical compositions of the SMIs, and methods for treating patients suffering from disorders characterized increased expression or excitation of the Prolactin receptor, including breast cancer, prostate cancer and nociceptive pain disorders such as migraine headache, by administering pharmaceutical compositions of SMIs are provided.
    Type: Application
    Filed: September 30, 2021
    Publication date: January 27, 2022
    Inventors: Nira Ben-Jonathan, Eric R. Hugo, Edward J. Merino, Abraham J. Domb, Armen N. Akopian
  • Small molecule prolactin receptor inhibitors, pharmaceutical compositions and treatment methods using such inhibitors
    Patent number: 11168061
    Abstract: Small molecule inhibitors (SMIs) of the Prolactin receptor, pharmaceutical compositions of the SMIs, and methods for treating patients suffering from disorders characterized increased expression or excitation of the Prolactin receptor, including breast cancer, prostate cancer and nociceptive pain disorders such as migraine headache, by administering pharmaceutical compositions of SMIs are provided.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: November 9, 2021
    Assignees: University of Cincinnati, University of Texas System, The Hebrew University of Jerusalem
    Inventors: Nira Ben-Jonathan, Eric R. Hugo, Edward J. Merino, Abraham J. Domb, Armen N. Akopian
  • Small Molecule Prolactin Receptor Inhibitors, Pharmaceutical Compositions and Treatment Methods Using Such Inhibitors
    Publication number: 20190202794
    Abstract: Small molecule inhibitors (SMIs) of the Prolactin receptor, pharmaceutical compositions of the SMIs, and methods for treating patients suffering from disorders characterized increased expression or excitation of the Prolactin receptor, including breast cancer, prostate cancer and nociceptive pain disorders such as migraine headache, by administering pharmaceutical compositions of SMIs are provided.
    Type: Application
    Filed: September 8, 2017
    Publication date: July 4, 2019
    Inventors: Nira Ben-Jonathan, Eric R. Hugo, Edward J. Merino, Abraham J. Domb, Armen N. Akopian